Copyright
©The Author(s) 2024.
World J Psychiatry. Jan 19, 2024; 14(1): 88-101
Published online Jan 19, 2024. doi: 10.5498/wjp.v14.i1.88
Published online Jan 19, 2024. doi: 10.5498/wjp.v14.i1.88
ID | Metabolite | Outcome | SNP, n | β | SE | P value |
M02137 | Biliverdin | ASD | 3 | -0.255 | 0.122 | 0.038 |
M20675 | 1,5-Anhydroglucitol | ASD | 5 | -0.881 | 0.407 | 0.031 |
M32412 | Butyrylcarnitine | ASD | 12 | -0.219 | 0.111 | 0.049 |
M32497 | 10-undecenoate (11:1n1) | ASD | 3 | 0.546 | 0.258 | 0.034 |
M32847 | X-11530 | ASD | 3 | -0.302 | 0.125 | 0.016 |
M33137 | X-11792 | ASD | 3 | 0.388 | 0.093 | 3.03 × 10-5 |
M33138 | Oxidized bilirubin | ASD | 3 | -0.318 | 0.148 | 0.032 |
M34306 | X-12696 | ASD | 4 | -0.831 | 0.325 | 0.011 |
M34407 | Isovalerylcarnitine | ASD | 4 | -0.976 | 0.393 | 0.013 |
M34420 | Des-Arg(9) bradykinin | ASD | 3 | 0.262 | 0.064 | 4.64 × 10-5 |
M36131 | Alpha-glutamyltyrosine | ASD | 3 | -0.619 | 0.213 | 0.004 |
- Citation: Huang ZY, Lyu ZP, Li HG, You HZ, Yang XN, Cha CH. Des-Arg(9) bradykinin as a causal metabolite for autism spectrum disorder. World J Psychiatry 2024; 14(1): 88-101
- URL: https://www.wjgnet.com/2220-3206/full/v14/i1/88.htm
- DOI: https://dx.doi.org/10.5498/wjp.v14.i1.88